QC
VERA icon

Quadrature Capital’s Vera Therapeutics VERA Stock Holding History

Quadrature Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,538
Closed -$424K – 2087
2026
Q1 		$424K Buy
+10,538
New +$454K 0.01% 850
2025
Q3 		– Sell
-36,136
Closed -$852K – 1517
2025
Q2 		$852K Buy
+36,136
New +$813K 0.01% 443

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Quadrature Capital's VERA Position: Q2 2026 in Review

Quadrature Capital sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 10,538 shares — an estimated $424K sold.

Quadrature Capital first reported a position in VERA in Q2 2025 and held it in 2 quarters. The position peaked at $852K in Q2 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Quadrature Capital reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 10,538 Vera Therapeutics shares in Q2 2026, an estimated $424K.
  • Quadrature Capital first reported a position in Vera Therapeutics in Q2 2025 and held it in 2 quarters.
  • Quadrature Capital's Vera Therapeutics position peaked at $852K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.